Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Irene Robinson

  • Home
  • Author: Irene Robinson

Bausch Health looks to Allegro to create long-term value

Bausch Health recently announced that it had entered into an agreement with Allegro to acquire an option to purchase all of the latter’s ophthalmology assets. This transaction will be a significant step for Bausch Health in its strategy to create a long-term growth opportunity, says GlobalData, a leading data and analytics company. Vinie Varkey, MSc, […]
Read more

Competition intensifies in SMA market with new Evrysdi two-year data

Following the news that Roche has announced new positive two-year data for Evrysdi (risdiplam) in infants with spinal muscular atrophy (SMA); Philippa Salter, Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “Having been approved earlier this year, Roche’s Evrysdi now reaches the market – albeit a whole four years behind […]
Read more

PAH patients to benefit amid telemedicine regulatory changes

Following President Trump’s announced executive order directing the Department of Health and Human Services (HHS) to issue rules ensuring that specific regulatory changes to telemedicine will remain in place once the COVID-19 pandemic ends, HHS will need to healthcare access to rural areas and to create a novel value-based payment model to improve reimbursement, according […]
Read more

UK car output trend a stark reminder that crisis persists

Following the news from the Society of Motor Manufacturers and Traders (SMMT) that UK car manufacturing plunged by 44.6% in August; David Leggett, Automotive Analyst at GlobalData, a leading data and analytics company, offers his view:  “On the upside, we have seen a solid manufacturing restart in Britain’s car industry since the spring, but this latest […]
Read more

COVID-19 pandemic impacting robotic surgical systems market with 7.7% lost revenue expected in 2020

Nearly 8% of revenue from robotic surgical systems will be lost in 2020 due to COVID-19, according to GlobalData, a leading data and analytics company, as many elective robotic surgical procedures have been postponed. Given that Intuitive Surgical is the market leader for robotic surgical systems sales, most revenue lost during the COVID-19 pandemic will be experienced by this company. For […]
Read more

Level 2 ADAS technologies trickling down car segments

While advanced driver assistance systems (ADAS) technologies have appeared in luxury cars for some time, they are increasingly appearing in less expensive cars, according to GlobalData, a leading data and analytics company. The objective is, at best, to prevent accidents completely and, at worst, minimise the consequences of an accident for all involved. David Leggett, Automotive Analyst at GlobalData, […]
Read more

AR uptake will increase in aerospace and defense as vendors realize benefits of utilizing the technology

Augmented reality (AR) is expected to see significantly more uptake in the aerospace and defense sectors in the coming decade as vendors realize the benefits of utilizing this technology in manufacturing processes. Militaries are currently investing in AR, in a limited sense, but are refraining from deploying it in the field until the technology is […]
Read more

Thermo Fisher’s failed Qiagen acquisition will not significantly affect its future growth

Following the collapse of Thermo Fisher Scientific’s $11.5bn takeover of Qiagen; Brian Hicks, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers his view: “As one of the largest acquisitions in the MedTech industry to have potentially occurred in 2020, a successful deal would have propelled Thermo Fisher’s market capitalization by nearly 7%, […]
Read more

Quidel’s revenues will continue to climb in 2020

Following the release of Quidel’s Q2 2020 results; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “Quidel has risen dramatically this year due to its flexible, diverse and speedy COVID-19 offerings. With the pandemic still present, especially in the US and South America, and the threat of […]
Read more

Novaliq’s CyclASol could become preferred cyclosporine formulation if pivotal trial succeeds

Novaliq recently announced its agreement with the US Food and Drug Administration (FDA) regarding the second registrational trial ESSENCE-2 for its late-stage therapy, CyclASol, for dry eye syndrome (DES). This is a positive development for the DES market, particularly due to its favorable tolerability profile, according to GlobalData, a leading data and analytics company. ESSENCE-2 […]
Read more

AstraZeneca’s Breztri will overcome late entry to COPD market

Following the news that the Food and Drug Administration granted AstraZeneca’s Breztri approval in the US for chronic obstructive pulmonary disease (COPD); Angad Lotay, MPharm, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “Despite its late market entry, GlobalData believes AstraZeneca will still catapult ahead, not only in COPD patients, but eventually […]
Read more

Incyte’s Jakafi poised to become leader in rapidly growing GvHD market

Following today’s news (Thursday 23 July) that Incyte’s Jakafi (ruxolitinib) met its primary endpoint in its Phase III REACH-3 chronic graft-versus-host-disease (GvHD) study; James Mather, MChem, Managing Immunology & Respiratory Analyst at GlobalData, a leading data and analytics company, offers his view: “In the top-line results announced by Incyte, Jakafi demonstrated a superior overall response […]
Read more
1 … 8 9 10 11 12 … 15